These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27049261)

  • 1. DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer.
    Long JP; Wan F; Zhang F; Zhou J; Don LF
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1087-92. PubMed ID: 27049261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH
    World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
    Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
    Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model.
    Melekoglu R; Ciftci O; Eraslan S; Cetin A; Basak N
    J Ovarian Res; 2018 Apr; 11(1):33. PubMed ID: 29699594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer.
    Falkson CI; Falkson HC; Falkson G
    Eur J Cancer; 1991; 27(10):1208-11. PubMed ID: 1835587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
    McCune JS; Games DM; Espirito JL
    J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
    Demeestere I; Brice P; Peccatori FA; Kentos A; Gaillard I; Zachee P; Casasnovas RO; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
    J Clin Oncol; 2013 Mar; 31(7):903-9. PubMed ID: 23129737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer.
    Zhang XH; Hao S; Gao B; Tian WG; Jiang Y; Zhang S; Guo LJ; Luo DL
    Oncotarget; 2016 Dec; 7(51):84533-84543. PubMed ID: 27811367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
    J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1257-62. PubMed ID: 26756114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
    Yasumura T; Oka T; Honjo H; Okada H
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.
    Oostra DR; Lustberg MB; Reinbolt RE; Pan X; Wesolowski R; Shapiro CL
    Mol Cell Endocrinol; 2015 Feb; 402():51-6. PubMed ID: 25575458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials.
    Furlanetto J; Marmé F; Seiler S; Thode C; Untch M; Schmatloch S; Schneeweiss A; Bassy M; Fasching PA; Strik D; Stickeler E; Schem C; Karn T; Grischke EM; Denkert C; van Mackelenbergh M; Müller V; Nekljudova V; Loibl S
    Eur J Cancer; 2021 Jul; 152():193-203. PubMed ID: 34116270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure.
    Welt CK; Hall JE; Adams JM; Taylor AE
    J Clin Endocrinol Metab; 2005 Feb; 90(2):826-30. PubMed ID: 15562017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decrease of testosterone level in blood of breast cancer patients of reproductive age after neoadjuvant chemotherapy].
    Bershteĭn LM; Boriakina MP; Tsyrlina EV; Poroshina TE; Bozhok AA
    Vopr Onkol; 2012; 58(5):639-43. PubMed ID: 23600280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of comparison of CAF regimen and TP regimen in treatment of advanced breast cancer].
    Lin XG; Xie DR; Yao HR; Li ZH; Jiang ZM; Liu TH
    Ai Zheng; 2003 Apr; 22(4):411-4. PubMed ID: 12704001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.
    Gu X; Jia S; Wei W; Zhang WH
    Tumour Biol; 2015 Jul; 36(7):5529-35. PubMed ID: 25682286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.
    Berliere M; Dalenc F; Malingret N; Vindevogel A; Piette P; Roche H; Donnez J; Symann M; Kerger J; Machiels JP
    BMC Cancer; 2008 Feb; 8():56. PubMed ID: 18291033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.